CMND (CMND) Stock Price & Analysis
CMND (CMND) fell 3.01% to USD 1.61 as of July 25, 2026 at 03:05 UTC, according to Nexqual real-time market data.
CMND last closed at USD 1.66; the session ranged USD 1.61–1.68 on volume of 32,491 shares. Market capitalization is $2.39M, with a 52-week range of USD 1.61–524 (NCM). Source: Nexqual, July 25, 2026 at 03:05 UTC.
Key Statistics (as of July 25, 2026 at 03:05 UTC)
| Price | USD 1.61 |
|---|---|
| Change | ▼ 3.01% (down) |
| Previous Close | USD 1.66 |
| Open | USD 1.65 |
| Day Range | USD 1.61 – 1.68 |
| 52-Week Range | USD 1.61 – 524 |
| Volume | 32,491 shares |
| Market Cap | $2.39M |
| Exchange | NCM |
Technical Analysis (CMND)
Nexqual's technical model rates CMND "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 03:05 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 17.58 (oversold) |
| vs SMA50 | Below (USD 2.75) |
| MACD | -0.4 (negative) |
Analyst Ratings (CMND)
Wall Street analysts rate CMND "None", per Nexqual as of July 25, 2026 at 03:05 UTC.
| Consensus Rating | None |
|---|
Earnings (CMND)
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Financials & Fundamentals (CMND)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -114.61% |
| Debt / Equity | 0.75 |
| Current Ratio | 4.79 |
| Total Cash | $13.59M |
| Total Debt | $85,588 |
| Free Cash Flow | $-3.53M |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Financial Health Score (CMND)
Nexqual rates CMND's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:05 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Strong — $14M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$6M |
| Efficiency | Critical — ROE -115%, ROA -51.4% |
Ownership (CMND)
| Insider Ownership | +0.09% |
|---|---|
| Institutional Ownership | +128.63% |
| Shares Outstanding | 1.49M |
| Float | 1.48M |
| Short % of Float | +13.69% |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Leadership (CMND)
CMND is led by Adi Zuloff-Shani (age 58), Chief Executive Officer, per Nexqual as of July 25, 2026 at 03:05 UTC.
| Chief Executive Officer | Adi Zuloff-Shani (age 58) |
|---|---|
| Vice President of Business Development | Mark Haden M.S.W. (age 72) |
Major Backers & Investors (CMND)
Notable institutional backers of CMND include Xtx Topco Ltd, HRT Financial LP, AdvisorShares Trust-AdvisorShares Psychedelics ETF, according to Nexqual as of July 25, 2026 at 03:05 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Xtx Topco Ltd | 0.21% |
| HRT Financial LP | 0.16% |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 0.11% |
Source: Nexqual, July 25, 2026 at 03:05 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.55 | ▼ 7.74% |
| BDRX | Biodexa Pharmaceuticals plc | USD 1.65 | ▼ 3.51% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
| NEXR | Nexera Technologies Ltd | USD 0.33 | ▼ 10.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:05 UTC. This page is informational and not investment advice.